PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
25-Jul-2022 Full-process Services of Eukaryotic Microbial 18S Sequencing at Creative Biogene Creative Biogene
25-Jul-2022 Novotech's Flexible Work Policy is Finalist in Best Workplace Flexibility Program "Excellence Award 2022" Novotech Health Holdings Pte Ltd
25-Jul-2022 Alfa Chemistry Testing Lab Releases Detergent and Cleaner Testings for Better Market Transparency Alfa Chemistry Testing Lab
22-Jul-2022 Trainee doctors with higher BMAT scores are more likely to pass MRCP postgrad medical examinations conscious comms
22-Jul-2022 Sampled Appoints Sarah Hersey, VP, Head of Translational Sciences & Diagnostics at Bristol Myers Squibb, as its First Independent Director Sampled
22-Jul-2022 Sampled Expand Global Footprint with New Lab in UK Sampled
22-Jul-2022 ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing Authorization by the European Commission for Upstaza™ - First Disease-Modifying Treatment for AADC Deficiency Clear Point Neuro
21-Jul-2022 Major Shareholder Announcement Genmab A/S
21-Jul-2022 Navigo Proteins Successfully Develops Affinity Resin Against Ferritin for Blood Fraction Processing Navigo Proteins GmbH
21-Jul-2022 MicrobioSeq Supercharges Microbial Research by Bacterial Whole Genome De Novo Sequencing CD Genomics
21-Jul-2022 CD Genomics Unveils Chloroplast DNA (cpDNA) Sequencing Service for Your Biological Research CD Genomics
20-Jul-2022 A new measure of psychological safety for patients University of Strathclyde
20-Jul-2022 ALLIANCE PHARMA Half Year Trading Update ALLIANCE PHARMA
20-Jul-2022 Almirall launches new call to find innovative therapies for skin diseases Almirall
20-Jul-2022 Resolution Therapeutics Appoints Dr. Bill Symonds to its Board of Directors Resolution Therapeutics
20-Jul-2022 Robocath’s joint venture, Cathbot, concludes first clinical study in China to evaluate robotic PCI safety and efficacy Andrew Lloyd Associates
20-Jul-2022 Forbion appoints Dr. Peter Høngaard Andersen as Operating Partner and Dr. Matt Cooper as Venture Partner Forbion
19-Jul-2022 Genmab Announces Net Sales of DARZALEX® (daratumumab) for the Second Quarter of 2022 Genmab
19-Jul-2022 Genmab Announces That AbbVie Will Submit Marketing Authorization Application to European Medicines Agency for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Genmab
18-Jul-2022 TrialWire Technology Platform Announces Success-based Patient Recruitment Plan TrialWire